Viewing Study NCT02869295


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2026-03-30 @ 1:41 PM
Study NCT ID: NCT02869295
Status: COMPLETED
Last Update Posted: 2021-07-29
First Post: 2016-08-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Sponsor: Nektar Therapeutics
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-12
Start Date Type: ACTUAL
Primary Completion Date: 2018-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2018-10-31
Completion Date Type: ACTUAL
First Submit Date: 2016-08-03
First Submit QC Date: None
Study First Post Date: 2016-08-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-05-02
Results First Submit QC Date: None
Results First Post Date: 2021-07-29
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-07-09
Last Update Post Date: 2021-07-29
Last Update Post Date Type: ACTUAL